Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DVS Sciences and Cytobank Announce Partnership

Published: Monday, June 25, 2012
Last Updated: Monday, June 25, 2012
Bookmark and Share
Companies join forces to analyze and manage high-parameter mass cytometry data.

DVS Sciences, Inc. announced a business agreement with Cytobank, Inc., a privately held developer of cloud based scientific, informatics and software solutions for the flow cytometry market.

The CyTOF mass cytometry platform developed by DVS Sciences enables revolutionary understanding of cellular dynamics of disease states, identification of stem cells and unprecedented insight into other biological systems using metal conjugated antibodies bound to cells and analyzed by time of flight mass spectrometry. The technology uniquely has the capability to simultaneously measure up to 100 cell biomarkers in single cells at up to 1000 cells per second. The software platform created by Cytobank enables researchers to analyze and manage the data acquired on CyTOF instruments using a novel cloud computing platform integrated with proprietary algorithms for data analysis. Together, DVS Sciences and Cytobank will co-develop and release an integrated solution, "DVS Cytobank(TM)", that automatically analyzes and manages the large data sets resulting from CyTOF instruments, while concurrently providing information on reagent panels and protocols. The new venture enables and simplifies the analysis of the massively multi-parameter mass cytometry data. DVS Cytobank is a proprietary implementation developed specifically for mass cytometry data, capitalizing on the Cytobank platform and provided by DVS Sciences directly to researchers using the CyTOF platform.

"The marriage of uniquely informative data acquired by our CyTOF instruments and reagents with the powerful capabilities of the Cytobank cloud based platform will be enabling for our researchers around the world as they analyze, manage, and share large amounts of multi-parameter data," says Joseph Victor, President & CEO of DVS Sciences. Nikesh Kotecha, Ph.D , CEO & Co-founder of Cytobank adds, "we are excited to be partnering with DVS Sciences to create a software solution that enables the next generation of high dimensional cytometry and single cell systems biology brought about by the CyTOF instrument."

An early access version of DVS Cytobank will be released to the customers of DVS Sciences in August with a formal release available by November, 2012.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Google and EI Partner for Next Generation of Coders
The Earlham Institute's open-source project for visualisation of biological data BioJS acts as mentor organisation for Google Summer of Code 2016.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!